Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)The Effect of N115 on Coughing in IPF Patients
Phase 3
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- Other: Saline Placebo control nasal sprayDrug: 20mM sodium pyruvate nasal spray
- First Posted Date
- 2023-09-14
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- Cellular Sciences, inc.
- Target Recruit Count
- 50
- Registration Number
- NCT06037408
- Locations
- ๐บ๐ธ
Family First Medical Research Center, Hialeah Gardens, Florida, United States
Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.
Phase 2
Completed
- Conditions
- Long COVID
- Interventions
- Drug: sodium pyruvate nasal spray
- First Posted Date
- 2021-05-04
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- Cellular Sciences, inc.
- Target Recruit Count
- 22
- Registration Number
- NCT04871815
- Locations
- ๐บ๐ธ
Missouri State University, Springfield, Missouri, United States
Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2022-11-02
- Lead Sponsor
- Cellular Sciences, inc.
- Target Recruit Count
- 30
- Registration Number
- NCT04824365
- Locations
- ๐บ๐ธ
Family First Medical Research Center, Virginia Gardens, Florida, United States
๐บ๐ธMissouri State University, Springfield, Missouri, United States
News
No news found